Name: The Dark Proteome Awakening - How Microproteins Are Revolutionizing Cancer Therapy (en Inglés)
SKU: 66855039
Price: 169.82 PEN
Availability: InStock
Author: Fierro-Monti, Ivo
ISBN: 9789999330299

portada The Dark Proteome Awakening - How Microproteins Are Revolutionizing Cancer Therapy (en Inglés)

The Dark Proteome Awakening - How Microproteins Are Revolutionizing Cancer Therapy (en Inglés)

Formato

Libro Físico

Editorial

Eliva Press

Autor

Fierro-Monti, Ivo

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x0.2 cm

ISBN13

9789999330299

The Dark Proteome Awakening - How Microproteins Are Revolutionizing Cancer Therapy (en Inglés)

Fierro-Monti, Ivo (Autor) · Eliva Press · Tapa Blanda

Más barato Libro Nuevo Importado

Envío: 14 a 19 días háb.

S/ 377,39S/ 169,82

-55%

Más rápido Libro Nuevo Importado

Envío: 13 a 17 días háb.

S/ 380,00S/ 171,00

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo Más barato

Quedan 100 unidades

S/ 169,82

Llega entre el 01 Oct y el 12 Oct a CERCADO DE LIMA, Lima. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "The Dark Proteome Awakening - How Microproteins Are Revolutionizing Cancer Therapy (en Inglés)"

Hidden microproteins, big hope: the "dark proteome" steps into the cancer spotlight. For decades we treated most of our DNA as "junk." Now, a microscopic revolution is overturning that dogma. Buried inside regions once dismissed as silent are thousands of newly discovered micro-genes (non canonical open reading frames, ncORFs) that churn out ultra-small proteins (recently called "peptideins", between peptides and proteins). These nano-sized guardians and saboteurs are rewriting the rules of cancer biology. In liver tumors they masquerade as unique flags that immune cells can learn to attack. In childhood brain cancer they hijack repair machines to keep malignant cells alive. In resistant breast tumors a single ncORF protein pumps drugs out before they can work. Using cutting-edge "molecular flash photography" (Ribo-Seq) and ultra-sensitive mass spectrometry, scientists are finally seeing these invisible actors in action. CRISPR gene-editing is now switching them on and off like light-bulbs, revealing which ones are essential for cancer survival-and which ones could become personal vaccines or next-generation drugs. From bench to bedside, the dark proteome is lighting up new paths to earlier diagnosis, smarter immunotherapies and precision medicines that were unimaginable just five years ago. The smallest proteins in nature may soon deliver the biggest victories against cancer.